Loading…

Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells

Cancer stem cells (CSCs) are thought to play important roles in carcinogenesis, recurrence, metastasis, and therapy-resistance. We have successfully induced cancer stem-like sphere cells (CSLCs) which possess enhanced chemoresistance and metastatic potential. To enable the development of targeted th...

Full description

Saved in:
Bibliographic Details
Published in:BMC cancer 2022-03, Vol.22 (1), p.260-260, Article 260
Main Authors: Tsunedomi, Ryouichi, Yoshimura, Kiyoshi, Kimura, Yuta, Nishiyama, Mitsuo, Fujiwara, Nobuyuki, Matsukuma, Satoshi, Kanekiyo, Shinsuke, Matsui, Hiroto, Shindo, Yoshitaro, Watanabe, Yusaku, Tokumitsu, Yukio, Yoshida, Shin, Iida, Michihisa, Suzuki, Nobuaki, Takeda, Shigeru, Ioka, Tatsuya, Hazama, Shoichi, Nagano, Hiroaki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c666t-88fe41372d4dee874021ac20a39181f148e69fe55b12a25014b85d933566257a3
cites cdi_FETCH-LOGICAL-c666t-88fe41372d4dee874021ac20a39181f148e69fe55b12a25014b85d933566257a3
container_end_page 260
container_issue 1
container_start_page 260
container_title BMC cancer
container_volume 22
creator Tsunedomi, Ryouichi
Yoshimura, Kiyoshi
Kimura, Yuta
Nishiyama, Mitsuo
Fujiwara, Nobuyuki
Matsukuma, Satoshi
Kanekiyo, Shinsuke
Matsui, Hiroto
Shindo, Yoshitaro
Watanabe, Yusaku
Tokumitsu, Yukio
Yoshida, Shin
Iida, Michihisa
Suzuki, Nobuaki
Takeda, Shigeru
Ioka, Tatsuya
Hazama, Shoichi
Nagano, Hiroaki
description Cancer stem cells (CSCs) are thought to play important roles in carcinogenesis, recurrence, metastasis, and therapy-resistance. We have successfully induced cancer stem-like sphere cells (CSLCs) which possess enhanced chemoresistance and metastatic potential. To enable the development of targeted therapy against CSLCs, we identified a gene responsible for this phenotype in CSLC. Human hepatoma cell line SK-HEP-1 was used for CSLC induction with a unique sphere inducing medium, and HuH-7 cells were used as non-sphere forming cells in the same condition. RNA-sequencing was performed followed by validation with quantitative RT-PCR and western blotting. Knockdown experiments were done by using CRISPR-Cas9 genome-editing, and the rescue experiments were performed using the expressing plasmid vector. Chemoresistance and liver metastasis of the cells, was studied following the splenic injection of cells to severely immune deficient mice and evaluated using the MTS assay. Quantification of exosomes in the medium was done using ELISA. RAB3B was identified as an up-regulated gene in both CSLCs and prognostically poor hepatocellular carcinoma (HCC) by RNA-sequencing. RAB3B-KD cells showed altered CSLC phenotypes such as sphere formation, chemoresistance, and metastatic potentials, and those were rescued by RAB3B complementation. Increased exosome secretion was observed in CSLCs, and it was not observed in the RAB3B-KD cells. In addition, the RAB3B expression correlated with the expression of ABCG2, APOE, LEPR, LXN, and TSPAN13. The up regulation of RAB3B may play an important role in the chemoresistance and metastatic potential of CSLCs.
doi_str_mv 10.1186/s12885-022-09370-1
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4ba9390be14d4630a56ccd087fcb0797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A699522445</galeid><doaj_id>oai_doaj_org_article_4ba9390be14d4630a56ccd087fcb0797</doaj_id><sourcerecordid>A699522445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c666t-88fe41372d4dee874021ac20a39181f148e69fe55b12a25014b85d933566257a3</originalsourceid><addsrcrecordid>eNptkl9rFDEUxQdRbK1-AR8kIIg-TM3fSeZF2JaqhYJQ9TncydzZTZmZjJNsab-92W4tOyB5SO7N7xySyymKt4yeMmaqz5FxY1RJOS9pLTQt2bPimEnNSi6pfn5wPipexXhDKdOGmpfFkVBca8blcTFd9HgLCVuCd9OMMfowktCR69WZOCNTD_eR-GEKc4IxkTn0mOuRuA0OIeM-5r5DAmNLBkyQy-QdmULCMXnod1YbnCCFAYjDvo-vixcd9BHfPO4nxe-vF7_Ov5dXP75dnq-uSldVVSqN6VAyoXkrW0SjJeUMHKcgamZYx6TBqu5QqYZx4Ioy2RjV1kKoquJKgzgpLve-bYAbO81-gPneBvD2oRHmtYU5v7VHKxuoRU0bZLKVlaCgKudaanTnGqprnb2-7L2mbTNg6_LfZugXpsub0W_sOtxaUzOteZ0NPj4azOHPFmOyg4-7ccCIYRstr4TRTHPJM_p-j64hP82PXciObofbVVXXinMpVaZO_0Pl1eLgXRix87m_EHxaCDKT8C6tYRujvfx5vWQ_HLAbhD5tYui3KWcjLkG-B90cYpyxexoJo3YXUbuPqM0RtQ8RtSyL3h0O80nyL5PiL91V36Y</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638717242</pqid></control><display><type>article</type><title>Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Tsunedomi, Ryouichi ; Yoshimura, Kiyoshi ; Kimura, Yuta ; Nishiyama, Mitsuo ; Fujiwara, Nobuyuki ; Matsukuma, Satoshi ; Kanekiyo, Shinsuke ; Matsui, Hiroto ; Shindo, Yoshitaro ; Watanabe, Yusaku ; Tokumitsu, Yukio ; Yoshida, Shin ; Iida, Michihisa ; Suzuki, Nobuaki ; Takeda, Shigeru ; Ioka, Tatsuya ; Hazama, Shoichi ; Nagano, Hiroaki</creator><creatorcontrib>Tsunedomi, Ryouichi ; Yoshimura, Kiyoshi ; Kimura, Yuta ; Nishiyama, Mitsuo ; Fujiwara, Nobuyuki ; Matsukuma, Satoshi ; Kanekiyo, Shinsuke ; Matsui, Hiroto ; Shindo, Yoshitaro ; Watanabe, Yusaku ; Tokumitsu, Yukio ; Yoshida, Shin ; Iida, Michihisa ; Suzuki, Nobuaki ; Takeda, Shigeru ; Ioka, Tatsuya ; Hazama, Shoichi ; Nagano, Hiroaki</creatorcontrib><description>Cancer stem cells (CSCs) are thought to play important roles in carcinogenesis, recurrence, metastasis, and therapy-resistance. We have successfully induced cancer stem-like sphere cells (CSLCs) which possess enhanced chemoresistance and metastatic potential. To enable the development of targeted therapy against CSLCs, we identified a gene responsible for this phenotype in CSLC. Human hepatoma cell line SK-HEP-1 was used for CSLC induction with a unique sphere inducing medium, and HuH-7 cells were used as non-sphere forming cells in the same condition. RNA-sequencing was performed followed by validation with quantitative RT-PCR and western blotting. Knockdown experiments were done by using CRISPR-Cas9 genome-editing, and the rescue experiments were performed using the expressing plasmid vector. Chemoresistance and liver metastasis of the cells, was studied following the splenic injection of cells to severely immune deficient mice and evaluated using the MTS assay. Quantification of exosomes in the medium was done using ELISA. RAB3B was identified as an up-regulated gene in both CSLCs and prognostically poor hepatocellular carcinoma (HCC) by RNA-sequencing. RAB3B-KD cells showed altered CSLC phenotypes such as sphere formation, chemoresistance, and metastatic potentials, and those were rescued by RAB3B complementation. Increased exosome secretion was observed in CSLCs, and it was not observed in the RAB3B-KD cells. In addition, the RAB3B expression correlated with the expression of ABCG2, APOE, LEPR, LXN, and TSPAN13. The up regulation of RAB3B may play an important role in the chemoresistance and metastatic potential of CSLCs.</description><identifier>ISSN: 1471-2407</identifier><identifier>EISSN: 1471-2407</identifier><identifier>DOI: 10.1186/s12885-022-09370-1</identifier><identifier>PMID: 35277124</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Analysis ; Cancer cells ; Cancer stem cell ; Care and treatment ; Diagnosis ; Exosome ; Hepatoma ; Leptin ; Metastasis ; Prevention ; RAB3B ; Risk factors ; Sphere ; Stem cells ; Transplantation</subject><ispartof>BMC cancer, 2022-03, Vol.22 (1), p.260-260, Article 260</ispartof><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c666t-88fe41372d4dee874021ac20a39181f148e69fe55b12a25014b85d933566257a3</citedby><cites>FETCH-LOGICAL-c666t-88fe41372d4dee874021ac20a39181f148e69fe55b12a25014b85d933566257a3</cites><orcidid>0000-0003-4251-1936</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917729/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917729/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,36994,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35277124$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsunedomi, Ryouichi</creatorcontrib><creatorcontrib>Yoshimura, Kiyoshi</creatorcontrib><creatorcontrib>Kimura, Yuta</creatorcontrib><creatorcontrib>Nishiyama, Mitsuo</creatorcontrib><creatorcontrib>Fujiwara, Nobuyuki</creatorcontrib><creatorcontrib>Matsukuma, Satoshi</creatorcontrib><creatorcontrib>Kanekiyo, Shinsuke</creatorcontrib><creatorcontrib>Matsui, Hiroto</creatorcontrib><creatorcontrib>Shindo, Yoshitaro</creatorcontrib><creatorcontrib>Watanabe, Yusaku</creatorcontrib><creatorcontrib>Tokumitsu, Yukio</creatorcontrib><creatorcontrib>Yoshida, Shin</creatorcontrib><creatorcontrib>Iida, Michihisa</creatorcontrib><creatorcontrib>Suzuki, Nobuaki</creatorcontrib><creatorcontrib>Takeda, Shigeru</creatorcontrib><creatorcontrib>Ioka, Tatsuya</creatorcontrib><creatorcontrib>Hazama, Shoichi</creatorcontrib><creatorcontrib>Nagano, Hiroaki</creatorcontrib><title>Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells</title><title>BMC cancer</title><addtitle>BMC Cancer</addtitle><description>Cancer stem cells (CSCs) are thought to play important roles in carcinogenesis, recurrence, metastasis, and therapy-resistance. We have successfully induced cancer stem-like sphere cells (CSLCs) which possess enhanced chemoresistance and metastatic potential. To enable the development of targeted therapy against CSLCs, we identified a gene responsible for this phenotype in CSLC. Human hepatoma cell line SK-HEP-1 was used for CSLC induction with a unique sphere inducing medium, and HuH-7 cells were used as non-sphere forming cells in the same condition. RNA-sequencing was performed followed by validation with quantitative RT-PCR and western blotting. Knockdown experiments were done by using CRISPR-Cas9 genome-editing, and the rescue experiments were performed using the expressing plasmid vector. Chemoresistance and liver metastasis of the cells, was studied following the splenic injection of cells to severely immune deficient mice and evaluated using the MTS assay. Quantification of exosomes in the medium was done using ELISA. RAB3B was identified as an up-regulated gene in both CSLCs and prognostically poor hepatocellular carcinoma (HCC) by RNA-sequencing. RAB3B-KD cells showed altered CSLC phenotypes such as sphere formation, chemoresistance, and metastatic potentials, and those were rescued by RAB3B complementation. Increased exosome secretion was observed in CSLCs, and it was not observed in the RAB3B-KD cells. In addition, the RAB3B expression correlated with the expression of ABCG2, APOE, LEPR, LXN, and TSPAN13. The up regulation of RAB3B may play an important role in the chemoresistance and metastatic potential of CSLCs.</description><subject>Analysis</subject><subject>Cancer cells</subject><subject>Cancer stem cell</subject><subject>Care and treatment</subject><subject>Diagnosis</subject><subject>Exosome</subject><subject>Hepatoma</subject><subject>Leptin</subject><subject>Metastasis</subject><subject>Prevention</subject><subject>RAB3B</subject><subject>Risk factors</subject><subject>Sphere</subject><subject>Stem cells</subject><subject>Transplantation</subject><issn>1471-2407</issn><issn>1471-2407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkl9rFDEUxQdRbK1-AR8kIIg-TM3fSeZF2JaqhYJQ9TncydzZTZmZjJNsab-92W4tOyB5SO7N7xySyymKt4yeMmaqz5FxY1RJOS9pLTQt2bPimEnNSi6pfn5wPipexXhDKdOGmpfFkVBca8blcTFd9HgLCVuCd9OMMfowktCR69WZOCNTD_eR-GEKc4IxkTn0mOuRuA0OIeM-5r5DAmNLBkyQy-QdmULCMXnod1YbnCCFAYjDvo-vixcd9BHfPO4nxe-vF7_Ov5dXP75dnq-uSldVVSqN6VAyoXkrW0SjJeUMHKcgamZYx6TBqu5QqYZx4Ioy2RjV1kKoquJKgzgpLve-bYAbO81-gPneBvD2oRHmtYU5v7VHKxuoRU0bZLKVlaCgKudaanTnGqprnb2-7L2mbTNg6_LfZugXpsub0W_sOtxaUzOteZ0NPj4azOHPFmOyg4-7ccCIYRstr4TRTHPJM_p-j64hP82PXciObofbVVXXinMpVaZO_0Pl1eLgXRix87m_EHxaCDKT8C6tYRujvfx5vWQ_HLAbhD5tYui3KWcjLkG-B90cYpyxexoJo3YXUbuPqM0RtQ8RtSyL3h0O80nyL5PiL91V36Y</recordid><startdate>20220311</startdate><enddate>20220311</enddate><creator>Tsunedomi, Ryouichi</creator><creator>Yoshimura, Kiyoshi</creator><creator>Kimura, Yuta</creator><creator>Nishiyama, Mitsuo</creator><creator>Fujiwara, Nobuyuki</creator><creator>Matsukuma, Satoshi</creator><creator>Kanekiyo, Shinsuke</creator><creator>Matsui, Hiroto</creator><creator>Shindo, Yoshitaro</creator><creator>Watanabe, Yusaku</creator><creator>Tokumitsu, Yukio</creator><creator>Yoshida, Shin</creator><creator>Iida, Michihisa</creator><creator>Suzuki, Nobuaki</creator><creator>Takeda, Shigeru</creator><creator>Ioka, Tatsuya</creator><creator>Hazama, Shoichi</creator><creator>Nagano, Hiroaki</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4251-1936</orcidid></search><sort><creationdate>20220311</creationdate><title>Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells</title><author>Tsunedomi, Ryouichi ; Yoshimura, Kiyoshi ; Kimura, Yuta ; Nishiyama, Mitsuo ; Fujiwara, Nobuyuki ; Matsukuma, Satoshi ; Kanekiyo, Shinsuke ; Matsui, Hiroto ; Shindo, Yoshitaro ; Watanabe, Yusaku ; Tokumitsu, Yukio ; Yoshida, Shin ; Iida, Michihisa ; Suzuki, Nobuaki ; Takeda, Shigeru ; Ioka, Tatsuya ; Hazama, Shoichi ; Nagano, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c666t-88fe41372d4dee874021ac20a39181f148e69fe55b12a25014b85d933566257a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analysis</topic><topic>Cancer cells</topic><topic>Cancer stem cell</topic><topic>Care and treatment</topic><topic>Diagnosis</topic><topic>Exosome</topic><topic>Hepatoma</topic><topic>Leptin</topic><topic>Metastasis</topic><topic>Prevention</topic><topic>RAB3B</topic><topic>Risk factors</topic><topic>Sphere</topic><topic>Stem cells</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsunedomi, Ryouichi</creatorcontrib><creatorcontrib>Yoshimura, Kiyoshi</creatorcontrib><creatorcontrib>Kimura, Yuta</creatorcontrib><creatorcontrib>Nishiyama, Mitsuo</creatorcontrib><creatorcontrib>Fujiwara, Nobuyuki</creatorcontrib><creatorcontrib>Matsukuma, Satoshi</creatorcontrib><creatorcontrib>Kanekiyo, Shinsuke</creatorcontrib><creatorcontrib>Matsui, Hiroto</creatorcontrib><creatorcontrib>Shindo, Yoshitaro</creatorcontrib><creatorcontrib>Watanabe, Yusaku</creatorcontrib><creatorcontrib>Tokumitsu, Yukio</creatorcontrib><creatorcontrib>Yoshida, Shin</creatorcontrib><creatorcontrib>Iida, Michihisa</creatorcontrib><creatorcontrib>Suzuki, Nobuaki</creatorcontrib><creatorcontrib>Takeda, Shigeru</creatorcontrib><creatorcontrib>Ioka, Tatsuya</creatorcontrib><creatorcontrib>Hazama, Shoichi</creatorcontrib><creatorcontrib>Nagano, Hiroaki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsunedomi, Ryouichi</au><au>Yoshimura, Kiyoshi</au><au>Kimura, Yuta</au><au>Nishiyama, Mitsuo</au><au>Fujiwara, Nobuyuki</au><au>Matsukuma, Satoshi</au><au>Kanekiyo, Shinsuke</au><au>Matsui, Hiroto</au><au>Shindo, Yoshitaro</au><au>Watanabe, Yusaku</au><au>Tokumitsu, Yukio</au><au>Yoshida, Shin</au><au>Iida, Michihisa</au><au>Suzuki, Nobuaki</au><au>Takeda, Shigeru</au><au>Ioka, Tatsuya</au><au>Hazama, Shoichi</au><au>Nagano, Hiroaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells</atitle><jtitle>BMC cancer</jtitle><addtitle>BMC Cancer</addtitle><date>2022-03-11</date><risdate>2022</risdate><volume>22</volume><issue>1</issue><spage>260</spage><epage>260</epage><pages>260-260</pages><artnum>260</artnum><issn>1471-2407</issn><eissn>1471-2407</eissn><abstract>Cancer stem cells (CSCs) are thought to play important roles in carcinogenesis, recurrence, metastasis, and therapy-resistance. We have successfully induced cancer stem-like sphere cells (CSLCs) which possess enhanced chemoresistance and metastatic potential. To enable the development of targeted therapy against CSLCs, we identified a gene responsible for this phenotype in CSLC. Human hepatoma cell line SK-HEP-1 was used for CSLC induction with a unique sphere inducing medium, and HuH-7 cells were used as non-sphere forming cells in the same condition. RNA-sequencing was performed followed by validation with quantitative RT-PCR and western blotting. Knockdown experiments were done by using CRISPR-Cas9 genome-editing, and the rescue experiments were performed using the expressing plasmid vector. Chemoresistance and liver metastasis of the cells, was studied following the splenic injection of cells to severely immune deficient mice and evaluated using the MTS assay. Quantification of exosomes in the medium was done using ELISA. RAB3B was identified as an up-regulated gene in both CSLCs and prognostically poor hepatocellular carcinoma (HCC) by RNA-sequencing. RAB3B-KD cells showed altered CSLC phenotypes such as sphere formation, chemoresistance, and metastatic potentials, and those were rescued by RAB3B complementation. Increased exosome secretion was observed in CSLCs, and it was not observed in the RAB3B-KD cells. In addition, the RAB3B expression correlated with the expression of ABCG2, APOE, LEPR, LXN, and TSPAN13. The up regulation of RAB3B may play an important role in the chemoresistance and metastatic potential of CSLCs.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>35277124</pmid><doi>10.1186/s12885-022-09370-1</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4251-1936</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2407
ispartof BMC cancer, 2022-03, Vol.22 (1), p.260-260, Article 260
issn 1471-2407
1471-2407
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4ba9390be14d4630a56ccd087fcb0797
source Publicly Available Content Database; PubMed Central
subjects Analysis
Cancer cells
Cancer stem cell
Care and treatment
Diagnosis
Exosome
Hepatoma
Leptin
Metastasis
Prevention
RAB3B
Risk factors
Sphere
Stem cells
Transplantation
title Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A18%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20expression%20of%20RAB3B%20plays%20important%20roles%20in%20chemoresistance%20and%20metastatic%20potential%20of%20hepatoma%20cells&rft.jtitle=BMC%20cancer&rft.au=Tsunedomi,%20Ryouichi&rft.date=2022-03-11&rft.volume=22&rft.issue=1&rft.spage=260&rft.epage=260&rft.pages=260-260&rft.artnum=260&rft.issn=1471-2407&rft.eissn=1471-2407&rft_id=info:doi/10.1186/s12885-022-09370-1&rft_dat=%3Cgale_doaj_%3EA699522445%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c666t-88fe41372d4dee874021ac20a39181f148e69fe55b12a25014b85d933566257a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2638717242&rft_id=info:pmid/35277124&rft_galeid=A699522445&rfr_iscdi=true